Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons prof. dr. A.K.L. (An) Reyners

Publicaties

Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial

Evaluation of the recently established Dutch nationwide Archipelago of Ovarian Cancer Research biobank

Genome-Wide DNA Methylation and Copy Number Alterations in Gastrointestinal Stromal Tumors

Impact of Mutation Profile on Outcomes of Neoadjuvant Therapy in GIST

Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel

Quality of life, neurocognitive functioning, psychological issues, sexuality and comorbidity more than 2 years after commencing immune checkpoint inhibitor treatment

Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer

Adverse events at the end of life of hospital patients with or without a condition relevant for palliative care: a nationwide retrospective record review study in the Netherlands

APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept study

Assessing the clinical benefit of systemic anti-cancer treatments in the Netherlands: The impact of different thresholds for effectiveness

Pers/media

Zorginstituut schrapt dure kankermedicijnen uit pakket, 'ze zijn niet effectief'

“Ik heb veel zin om deze bloeiende vereniging de komende jaren voor te zitten”

PASKWIL-2023 criteria voortgekomen uit testen diverse scenario’s

Ruim 6,6 miljoen subsidie van het KWF voor UMCG-onderzoekers

Onderzoekers UMCG krijgen 6,6 miljoen euro van KWF Kankerbestrijding

Lat omhoog voor nieuwe kankermedicatie

LUMC Prijzen, subsidies en benoemingen

Hoe voeg ik leven toe aan mijn dagen?